Third Time's the Charm: FDA Approves Replimune's Tudriqev (RP1) for Advanced Melanoma
Who Will Write the Next Chapter of Oncology? – CancerWorld
ORR vs OS: The Debate Continues on X
A Living Library of Cancer: New Models Could Help Researchers Find Better Treatments
Patient Advocate Training Opportunity
Metastatic Renal Cell Carcinoma in 2026: Frontline Combinations, Post-IO Sequencing, and the Emergence of HIF-2α Inhibition
Cancer Research Funding: Underfunded or Unequally Distributed?
Sequencing After Enfortumab Vedotin and Pembrolizumab in Advanced Urothelial Carcinoma
The ANCO’s Medicare Regulations Update 2026 webinar on January 14, 2026, will provide a comprehensive overview of the latest Medicare changes affecting oncology services. Bobbi Buell, MBA, will cover updates to the Physician Fee Schedule, coding and billing, evaluation and management, and incentive programs, offering essential insights for clinicians and practice teams. Register here.
ANCO's Clinical Cancer Update 2026, taking place January 23–25, 2026, at the Everline Resort and Spa, will highlight the latest breakthroughs in cancer treatment across multiple specialties, including breast, gastrointestinal, genitourinary, lung, hematologic, and CNS cancers. The three-day meeting offers cutting-edge clinical content, opportunities for professional networking, and insights into translational science, chemotherapy, radiation, and […]
Best of SABCS – West, taking place February 14, 2026, at the Intercontinental San Francisco, provides clinicians with the latest updates in breast cancer research, diagnosis, and treatment. The program highlights recent clinical trial results, advances in management of breast cancer subtypes, and evidence-based strategies to optimize patient care, offering AMA PRA Category 1 Credit […]
The 26th Multidisciplinary Management of Cancers: A Case-Based Approach, held March 6–8, 2026, at the Meritage Resort and Spa, will focus on the latest multidisciplinary strategies in clinical oncology. The […]
ANCO's Hematologic Malignancies Update 2026, held May 2–3, 2026, at the Hyatt Regency Monterey, will provide clinicians, nurses, nurse practitioners, and physician assistants with the latest advances in the treatment of hematologic malignancies. The two-day meeting features expert-led sessions on clinically relevant topics to support evidence-based practice in hematology and oncology.
